Unknown

Dataset Information

0

Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer.


ABSTRACT: Pancreatic cancer is one of the most aggressive malignancies and has a highly immunosuppressive tumour microenvironment. Immune checkpoint blockade has led to remarkable and durable objective responses in a number of malignancies and antibody-based strategies targeting programmed cell death protein 1 (PD-1) are showing promise where traditional modalities of surgery, radiotherapy, and chemotherapy have failed. In this study, we examined the clinical value of PD-1 protein expression by CD8+ peripheral T lymphocytes or tumour-infiltrating T lymphocytes (TILs) in pancreatic ductal adenocarcinoma (PDAC). Expression of PD-1 protein on CD8+ TILs correlated with overall survival and clinicopathological characteristics such as clinical stage, N classification, and M classification. Similar findings were observed for the expression of PD-1 protein on peripheral CD8+ T cells, whereas its expression on peripheral CD4+ T cells showed no significance. Comparison of the levels of PD-1 protein expressed by peripheral CD8+ T cells before and 4 weeks after surgery indicated that preoperative and postoperative status of peripheral PD-1 expression was unchanged. Our findings showed that PD-1 protein expressed by peripheral or tumour-infiltrated CD8+ T cells was a promising biomarker for diagnosis and prognosis in PDAC and might help guide future immunotherapies.

SUBMITTER: Shen T 

PROVIDER: S-EPMC5552822 | biostudies-other | 2017 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer.

Shen Tao T   Zhou Liangjing L   Shen Hua H   Shi Chengfei C   Jia Shengnan S   Ding Guo Ping GP   Cao Liping L  

Scientific reports 20170810 1


Pancreatic cancer is one of the most aggressive malignancies and has a highly immunosuppressive tumour microenvironment. Immune checkpoint blockade has led to remarkable and durable objective responses in a number of malignancies and antibody-based strategies targeting programmed cell death protein 1 (PD-1) are showing promise where traditional modalities of surgery, radiotherapy, and chemotherapy have failed. In this study, we examined the clinical value of PD-1 protein expression by CD8+ perip  ...[more]

Similar Datasets

| S-EPMC1805580 | biostudies-literature
| S-EPMC5601941 | biostudies-literature
| S-EPMC7717727 | biostudies-literature
| S-EPMC5448596 | biostudies-literature
| S-EPMC5642642 | biostudies-literature
| S-EPMC5342072 | biostudies-literature
| S-EPMC6461857 | biostudies-literature
| S-EPMC5641527 | biostudies-literature
| S-EPMC6853089 | biostudies-literature
| S-EPMC4882023 | biostudies-literature